Format

Send to

Choose Destination
J Gen Intern Med. 2008 May;23(5):528-35. doi: 10.1007/s11606-008-0524-1. Epub 2008 Mar 12.

Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2.

Author information

1
Division of Endocrinology and Metabolism, Emory University School of Medicine, Atlanta, GA, USA.

Abstract

BACKGROUND:

With positive results from diabetes prevention studies, there is interest in convenient ways to incorporate screening for glucose intolerance into routine care and to limit the need for fasting diagnostic tests.

OBJECTIVE:

The aim of this study is to determine whether random plasma glucose (RPG) could be used to screen for glucose intolerance.

DESIGN:

This is a cross-sectional study.

PARTICIPANTS:

The participants of this study include a voluntary sample of 990 adults not known to have diabetes.

MEASUREMENTS:

RPG was measured, and each subject had a 75-g oral glucose tolerance test several weeks later. Glucose intolerance targets included diabetes, impaired glucose tolerance (IGT), and impaired fasting glucose(110) (IFG(110); fasting glucose, 110-125 mg/dl, and 2 h glucose < 140 mg/dl). Screening performance was measured by area under receiver operating characteristic curves (AROC).

RESULTS:

Mean age was 48 years, and body mass index (BMI) was 30.4 kg/m(2); 66% were women, and 52% were black; 5.1% had previously unrecognized diabetes, and 24.0% had any "high-risk" glucose intolerance (diabetes or IGT or IFG(110)). The AROC was 0.80 (95% CI 0.74-0.86) for RPG to identify diabetes and 0.72 (0.68-0.75) to identify any glucose intolerance, both highly significant (p < 0.001). Screening performance was generally consistent at different times of the day, regardless of meal status, and across a range of risk factors such as age, BMI, high density lipoprotein cholesterol, triglycerides, and blood pressure.

CONCLUSIONS:

RPG values should be considered by health care providers to be an opportunistic initial screening test and used to prompt further evaluation of patients at risk of glucose intolerance. Such "serendipitous screening" could help to identify unrecognized diabetes and prediabetes.

PMID:
18335280
PMCID:
PMC2324161
DOI:
10.1007/s11606-008-0524-1
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center